Maik Lander becomes sole CEO of Virion\Serion GmbH

Dear Sir or Madam,

We are pleased to announce that Maik Lander has assumed sole management of the company with immediate effect.

Maik Lander, who holds a degree in biotechnology and chemical engineering, brings more than fifteen years of experience in the medical device industry. Since February 2026, he has been responsible for the strategic and operational development of Institut Virion\Serion GmbH and as of May 1, 2026, has taken over sole responsibility for the company’s management.

With this decision, the company is strengthening its management structure and establishing clear lines of responsibility for its future strategic development.

“I am grateful for the shareholders’ trust and look forward to consistently driving Virion\Serion’s successful development forward,” says Maik Lander. “Our focus remains on innovation, quality, and close collaboration with our partners and customers worldwide. For our customers and partners, everything essential remains unchanged: We continue to stand for high product quality, innovative strength, and reliable delivery capabilities. The usual processes will also remain in place.”

 

Download press release

 

Press contact:

pr@ virion-serion.de